Analysts expect NewGenIvf Group Ltd to report revenue of 68.87 M for 2026, against a range of 64.00 M to 73.74 M. The most recent reported year, 2025, came in at 4.73 M, a 5.4% miss against the 5.00 M consensus.
| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Reported (Actual) | 4.73 M | - | - | |
| High Estimate | 5.18 M | 73.74 M | 181.58 M | |
| Low Estimate | 4.82 M | 64.00 M | 162.85 M | |
| Consensus Estimate | 5.00 M | 68.87 M | 172.22 M |
Analysts expect NewGenIvf Group Ltd to report earnings per share of 14.88 for 2026, against a range of 13.86 to 15.90. The most recent reported year, 2025, came in at 9.12, a 99.1% miss against the 1,063.16 consensus.
| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Reported (Actual) | 9.12 | - | - | |
| High Estimate | 1,125.30 | 15.90 | 32.34 | |
| Low Estimate | 1,001.02 | 13.86 | 26.92 | |
| Consensus Estimate | 1,063.16 | 14.88 | 29.63 |